Results 171 to 180 of about 25,445 (232)
Recurrent skin and soft tissue infections (SSTIs) in three family members caused by methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) with Panton-Valentine leukocidin (PVL) exotoxin. [PDF]
Reed A.
europepmc +1 more source
Structural and functional insights into Pseudomonas aeruginosa's secretion systems 1-6: regulation, role in microbial keratitis and drug targets. [PDF]
Akter T +6 more
europepmc +1 more source
Invasive <i>streptococcus dysgalactiae</i> endocarditis with extensive multiorgan involvement. [PDF]
Chen IC, Rhyner D, Durisch N.
europepmc +1 more source
Bridging the blood-brain barrier: strategies to improve delivery of biologics to tumors in the brain. [PDF]
Gampa G +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of Infectious Diseases, 1973
Exotoxin A of Pseudomonas aeruginosa (PA-103) could be concentrated readily by precipitation with zinc acetate and ammonium sulfate. The toxin was purified by column chromatography with use of DEAE-cellulose and Sephadex G-200. The final product contained about 8,000 mouse LD,,0/mg of protein.
P V, Liu, S, Yoshii, H, Hsieh
openaire +2 more sources
Exotoxin A of Pseudomonas aeruginosa (PA-103) could be concentrated readily by precipitation with zinc acetate and ammonium sulfate. The toxin was purified by column chromatography with use of DEAE-cellulose and Sephadex G-200. The final product contained about 8,000 mouse LD,,0/mg of protein.
P V, Liu, S, Yoshii, H, Hsieh
openaire +2 more sources
Pseudomonas aeruginosa Exotoxin A
Journal of Burn Care & Rehabilitation, 1992Bacterial concentrations greater than 10(5) colony-forming units/gm of tissue prevent wound healing. However, it has not been determined whether it is the number of bacteria or a toxin produced by these organisms that impedes the wound healing process.
John P. Heggers +4 more
openaire +1 more source
Botulinum A exotoxin use in clinical dermatology
Journal of the American Academy of Dermatology, 1996Botulinum toxin (BT) prevents the release of acetylcholine at the neuromuscular junction and produces reversible paralysis of striated muscle. This effect was initially used for ophthalmologic indications, particularly strabismus. The idea of using the toxin for purely cosmetic purposes arose from the observation that therapy for facial dystonias ...
A, Carruthers, K, Kiene, J, Carruthers
openaire +2 more sources

